Redpoint Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.36M | Sell |
47,295
-8,446
| -15% | -$600K | 0.49% | 36 |
|
|
2022
Q2 | $4.29M | Buy |
55,741
+638
| +1% | +$49.1K | 0.51% | 38 |
|
|
2022
Q1 | $4.02M | Sell |
55,103
-723
| -1% | -$52.8K | 0.4% | 52 |
|
|
2021
Q4 | $3.48M | Sell |
55,826
-885
| -2% | -$55.2K | 0.28% | 87 |
|
|
2021
Q3 | $3.36M | Sell |
56,711
-2,722
| -5% | -$161K | 0.29% | 85 |
|
|
2021
Q2 | $3.97M | Hold |
59,433
| – | – | 0.32% | 73 |
|
|
2021
Q1 | $3.75M | Buy |
59,433
+305
| +0.5% | +$19.3K | 0.32% | 81 |
|
|
2020
Q4 | $3.67M | Buy |
59,128
+3,670
| +7% | +$228K | 0.37% | 66 |
|
|
2020
Q3 | $3.34M | Sell |
55,458
-77,356
| -58% | -$4.66M | 0.36% | 72 |
|
|
2020
Q2 | $7.81M | Sell |
132,814
-14,044
| -10% | -$826K | 0.43% | 56 |
|
|
2020
Q1 | $8.19M | Sell |
146,858
-9,153
| -6% | -$510K | 0.51% | 43 |
|
|
2019
Q4 | $10M | Buy |
156,011
+40,338
| +35% | +$2.59M | 0.49% | 41 |
|
|
2019
Q3 | $5.87M | Buy |
115,673
+820
| +0.7% | +$41.6K | 0.31% | 72 |
|
|
2019
Q2 | $5.21M | Sell |
114,853
-16,229
| -12% | -$736K | 0.28% | 84 |
|
|
2019
Q1 | $6.25M | Buy |
131,082
+1,789
| +1% | +$85.4K | 0.31% | 73 |
|
|
2018
Q4 | $6.72M | Sell |
129,293
-1,825
| -1% | -$94.9K | 0.39% | 56 |
|
|
2018
Q3 | $8.14M | Sell |
131,118
-3,007
| -2% | -$187K | 0.41% | 48 |
|
|
2018
Q2 | $7.42M | Hold |
134,125
| – | – | 0.4% | 55 |
|
|
2018
Q1 | $8.48M | Sell |
134,125
-5,833
| -4% | -$369K | 0.47% | 48 |
|
|
2017
Q4 | $8.58M | Buy |
+139,958
| New | +$8.58M | 0.47% | 46 |
|